Beacon Transcript – A new study found that marijuana may have a beneficial effect for epileptic patients as the cannabidiol oil was found to reduce both the frequency and the severity of seizures.
The new study was carried out by researchers from the University of Alabama at Birmingham scientists. Some of their research results were presented at the 70th Annual Meeting of the American Epilepsy Society.
The team of researchers presented a number of eleven abstracts with their study results. These were meant to demonstrate their observations in regards to the relation between marijuana and an epileptic patients treatment.
Researchers found that the cannabidiol oil or the CBD oil may actually help reduce the symptom duration and severity of epileptic seizures.
Their results were based on an open-label study involving 81 patients out of which 39 were adults and 42 children.
All of the involved patients were diagnosed with intractable epilepsy and were noted to have experienced 4 or more disease-caused seizures every month.
According to reports, the study, which was initiated in April 2015, registered its first results from the first research month.
The first month saw a 25 percent seizure frequency reduction in 68 percent of the involved epileptic patients. 58 percent of the patients had a more than 50 percent reduction rate, 36 percent had an over 75 percent seizure frequency reduction rate.
A further 9 percent of the patients were registered to actually be seizure-free. The first-month results were noticed to have also maintained over a three to six months time period.
Jerzy P. Szaflarski, an M.D., Ph.D., Department of Neurology professor and UAB Epilepsy Center Director went to offer details on the study.
According to Szaflarski, although evidence that the CBD oil may help reduce the seizure frequency had already existed, the severity decrease is a new discovery.
Martina Bebin, an M.D., neurology professor, and co-primary CBD study investigator offered further information.
Bebin acknowledged the study’s encouraging results, but also pointed out the fact that each and every epileptic patient may have a different reaction to CBD. As some were noted to have a higher response rate, others had none at all.
Whilst observing the seizure decrease rates, the researchers registered the following values. As 67 percent of the patients registered a higher than 50 percent seizure severity decrease, 33 percent did not register a decrease effect.
The six month following of 47 of the patients also registered different values. As such, 64 percent of them registered a higher than 50 percent decrease in seizure severity. The remaining 36 percent showed no decrease in severity.
Bebin went to explain that as each epileptic patient responds differently to the CBD, an optimal dose is person dependent.
As an optimal such dosage range, which ensures the patient’s maximum benefits does seem to exist, it should also be respected.
The researcher hypothesizes that a dosage outside of this range may not have an effect or may even potentially cause an adverse reaction.
This, amongst others, is one of the factors which will have to be analyzed in further studies as Bebin declares that the method must continue to be tested and analyzed.
Another factor to be determined by future studies will have to target the CBD’s efficiency or lack of effect in certain epileptic patients.
Image Source: Wikimedia